S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
NYSE:LH

Laboratory Co. of America Stock Forecast, Price & News

$228.90
+0.45 (+0.20 %)
(As of 01/22/2021 05:06 PM ET)
Add
Compare
Today's Range
$226.69
Now: $228.90
$229.16
50-Day Range
$196.64
MA: $208.56
$229.91
52-Week Range
$98.02
Now: $228.90
$230.77
Volume612,310 shs
Average Volume702,101 shs
Market Capitalization$22.29 billion
P/E Ratio26.65
Dividend YieldN/A
Beta1.09
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular and infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other procedures. In addition, it provides a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, QIAGEN N.V, Ciox Health, Circuit Clinical, and Riverside Medical Group. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Laboratory Co. of America logo

MarketRank

Overall MarketRank

1.43 out of 5 stars

Medical Sector

510th out of 1,922 stocks

Medical Laboratories Industry

9th out of 39 stocks

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127
Employees65,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$20.22 per share
Book Value$77.93 per share

Profitability

Net Income$823.80 million

Miscellaneous

Market Cap$22.29 billion
Next Earnings Date2/11/2021 (Confirmed)
OptionableOptionable
$228.90
+0.45 (+0.20 %)
(As of 01/22/2021 05:06 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Laboratory Co. of America (NYSE:LH) Frequently Asked Questions

How has Laboratory Co. of America's stock been impacted by Coronavirus (COVID-19)?

Laboratory Co. of America's stock was trading at $158.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LH stock has increased by 44.0% and is now trading at $228.90.
View which stocks have been most impacted by COVID-19
.

Is Laboratory Co. of America a buy right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last twelve months. There are currently 1 hold rating and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Laboratory Co. of America stock.
View analyst ratings for Laboratory Co. of America
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Laboratory Co. of America?

Wall Street analysts have given Laboratory Co. of America a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Laboratory Co. of America wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Laboratory Co. of America's CEO?

6,978 employees have rated Laboratory Co. of America CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Laboratory Co. of America's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Laboratory Co. of America's next earnings date?

Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Laboratory Co. of America
.

How can I listen to Laboratory Co. of America's earnings call?

Laboratory Co. of America will be holding an earnings conference call on Thursday, February 11th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) announced its quarterly earnings results on Sunday, November, 1st. The medical research company reported $8.41 EPS for the quarter, topping the consensus estimate of $5.31 by $3.10. The medical research company had revenue of $3.90 billion for the quarter, compared to analysts' expectations of $3.62 billion. Laboratory Co. of America had a net margin of 6.79% and a return on equity of 21.05%. The business's quarterly revenue was up 33.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.90 EPS.
View Laboratory Co. of America's earnings history
.

What price target have analysts set for LH?

16 brokerages have issued twelve-month price objectives for Laboratory Co. of America's stock. Their forecasts range from $170.00 to $260.00. On average, they anticipate Laboratory Co. of America's share price to reach $226.82 in the next year. This suggests that the stock has a possible downside of 0.9%.
View analysts' price targets for Laboratory Co. of America
or view Wall Street analyst' top-rated stocks.

Are investors shorting Laboratory Co. of America?

Laboratory Co. of America saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 1,760,000 shares, an increase of 25.7% from the December 15th total of 1,400,000 shares. Based on an average daily volume of 636,800 shares, the short-interest ratio is presently 2.8 days. Currently, 1.8% of the shares of the company are short sold.
View Laboratory Co. of America's Short Interest
.

Who are some of Laboratory Co. of America's key competitors?

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

Who are Laboratory Co. of America's key executives?

Laboratory Co. of America's management team includes the following people:
  • Mr. Adam H. Schechter, Pres, CEO & Chairman (Age 55, Pay $1.79M)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 59, Pay $1.46M)
  • Mr. Lance V. Berberian, Exec. VP and Chief Information & Technology Officer (Age 57, Pay $876.62k)
  • Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH, Exec. VP, Pres of Diagnostics & Chief Medical Officer (Age 46, Pay $3.36M)
  • Mr. Mark S. Schroeder, Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain (Age 59, Pay $3.19M)
  • Dr. Michelle Abelson, Laboratory Director of Operations
  • Mr. Peter J. Wilkinson, Sr. VP & Chief Accounting Officer (Age 49)
  • Dr. Marcia T. Eisenberg, Chief Scientific Officer & Sr. VP
  • Clarissa Willett, VP of Investor Relations
  • Ms. Sandra D. Van Der Vaart, Exec. VP, Chief Legal Officer, Chief Compliance Officer & Corp. Sec. (Age 60)

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by a number of retail and institutional investors. Top institutional shareholders include AMI Asset Management Corp (0.32%), Bartlett & Co. LLC (0.19%), Wedge Capital Management L L P NC (0.14%), DNB Asset Management AS (0.13%), Stack Financial Management Inc (0.11%) and Forte Capital LLC ADV (0.05%). Company insiders that own Laboratory Co. of America stock include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Judith C Seltz, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr.
View institutional ownership trends for Laboratory Co. of America
.

Which major investors are selling Laboratory Co. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Denali Advisors LLC, AMI Asset Management Corp, National Investment Services of America LLC, Pacer Advisors Inc., Smith Graham & Co. Investment Advisors LP, Cypress Capital Group, and American National Bank. Company insiders that have sold Laboratory Co. of America company stock in the last year include Der Vaart Sandra D Van, Jean-Luc Belingard, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson, and R Sanders Williams.
View insider buying and selling activity for Laboratory Co. of America
or view top insider-selling stocks.

Which major investors are buying Laboratory Co. of America stock?

LH stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Diversified Trust Co, Pendal Group Limited, Polianta Ltd, Bartlett & Co. LLC, Hotaling Investment Management LLC, Forte Capital LLC ADV, and IFM Investors Pty Ltd.
View insider buying and selling activity for Laboratory Co. of America
or or view top insider-buying stocks.

How do I buy shares of Laboratory Co. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $228.90.

How big of a company is Laboratory Co. of America?

Laboratory Co. of America has a market capitalization of $22.29 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis. Laboratory Co. of America employs 65,000 workers across the globe.

What is Laboratory Co. of America's official website?

The official website for Laboratory Co. of America is www.labcorp.com.

How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.